In these GEMMs, epithelium-specific expression of Cre recombinase induces mammary tumors driven by deletion of Trp53 alone, or in combination with deletion of Brca1, Brca2 or Cdh1 (encoding E-cadherin). The gene discussed is BRCA2; the disease is breast cancer.